Skip to main content
logo
HUTCHMED (China) Limited (AIM:HCM)
London flag London · Delayed Price · Currency is GBP · Price in GBX
203.00
-3.00 (-1.46%)
Mar 26, 2026, 4:35 PM GMT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Other Ventures
262.97M266.84M309.38M262.57M236.52M
Other Ventures Growth
-1.45%-13.75%17.83%11.01%19.60%
Oncology/Immunology - Marketed Products
214.36M271.53M164.17M124.64M-
Oncology/Immunology - Marketed Products Growth
-21.06%65.40%31.71%--
Oncology/Immunology - R&D
71.18M91.83M364.45M39.20M-
Oncology/Immunology - R&D Growth
-22.48%-74.80%829.67%--
Oncology/Immunology - R&D - PRC
----43.18M
Oncology/Immunology - R&D - PRC Growth
----320.79%
Oncology/Immunology - Marketed Products - PRC
----76.43M
Oncology/Immunology - Marketed Products - PRC Growth
----283.05%
Total
548.51M630.20M838.00M426.41M356.13M
Total Growth
-12.96%-24.80%96.52%19.73%56.21%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
People's Republic of China (PRC)
407.45M452.41M484.90M426.41M-
People's Republic of China (PRC) Growth
-9.94%-6.70%13.72%--
U.S. and Others
141.06M177.79M353.10M--
U.S. and Others Growth
-20.66%-49.65%---
Total
548.51M630.20M838.00M426.41M-
Total Growth
-12.96%-24.80%96.52%--
Source: S&P Global Market Intelligence.